These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 12930004

  • 1. Paraxanthine/caffeine ratio: as an index for CYP1A2 activity in polycyclic aromatic hydrocarbons exposed subjects.
    Wittayalertpanya S, Hinsui Y, Lawanprasert S.
    J Med Assoc Thai; 2003 Jun; 86 Suppl 2():S310-7. PubMed ID: 12930004
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Caffeine and paraxanthine HPLC assay for CYP1A2 phenotype assessment using saliva and plasma.
    Perera V, Gross AS, McLachlan AJ.
    Biomed Chromatogr; 2010 Oct; 24(10):1136-44. PubMed ID: 20853468
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics of caffeine in plasma and saliva, and the influence of caffeine abstinence on CYP1A2 metrics.
    Perera V, Gross AS, Xu H, McLachlan AJ.
    J Pharm Pharmacol; 2011 Sep; 63(9):1161-8. PubMed ID: 21827488
    [Abstract] [Full Text] [Related]

  • 8. Severe 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) intoxication: insights into the measurement of hepatic cytochrome P450 1A2 induction.
    Abraham K, Geusau A, Tosun Y, Helge H, Bauer S, Brockmöller J.
    Clin Pharmacol Ther; 2002 Aug; 72(2):163-74. PubMed ID: 12189363
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Why dried blood spots are an ideal tool for CYP1A2 phenotyping.
    De Kesel PM, Lambert WE, Stove CP.
    Clin Pharmacokinet; 2014 Aug; 53(8):763-71. PubMed ID: 24980692
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Induction of CYP1A1, CYP1A2, and CYP1B1 mRNAs by nitropolycyclic aromatic hydrocarbons in various human tissue-derived cells: chemical-, cytochrome P450 isoform-, and cell-specific differences.
    Iwanari M, Nakajima M, Kizu R, Hayakawa K, Yokoi T.
    Arch Toxicol; 2002 Jun; 76(5-6):287-98. PubMed ID: 12107646
    [Abstract] [Full Text] [Related]

  • 15. Sympathomimetic effects of paraxanthine and caffeine in humans.
    Benowitz NL, Jacob P, Mayan H, Denaro C.
    Clin Pharmacol Ther; 1995 Dec; 58(6):684-91. PubMed ID: 8529334
    [Abstract] [Full Text] [Related]

  • 16. Artemisinin and thiabendazole are potent inhibitors of cytochrome P450 1A2 (CYP1A2) activity in humans.
    Bapiro TE, Sayi J, Hasler JA, Jande M, Rimoy G, Masselle A, Masimirembwa CM.
    Eur J Clin Pharmacol; 2005 Nov; 61(10):755-61. PubMed ID: 16261361
    [Abstract] [Full Text] [Related]

  • 17. Differences in caffeine and paraxanthine metabolism between human and murine CYP1A2.
    Labedzki A, Buters J, Jabrane W, Fuhr U.
    Biochem Pharmacol; 2002 Jun 15; 63(12):2159-67. PubMed ID: 12110375
    [Abstract] [Full Text] [Related]

  • 18. The paraxanthine:caffeine ratio in serum or in saliva as a measure of CYP1A2 activity: when should the sample be obtained?
    Spigset O, Hägg S, Söderström E, Dahlqvist R.
    Pharmacogenetics; 1999 Jun 15; 9(3):409-12. PubMed ID: 10471076
    [No Abstract] [Full Text] [Related]

  • 19. The determination of the Paraxanthine/Caffeine ratio as a metabolic biomarker for CYP1A2 activity in various human matrices by UHPLC-ESIMS/MS.
    Lajin B, Schweighofer N, Goessler W, Obermayer-Pietsch B.
    Talanta; 2021 Nov 01; 234():122658. PubMed ID: 34364467
    [Abstract] [Full Text] [Related]

  • 20. Polycyclic Aromatic Hydrocarbon-induced Pulmonary Carcinogenesis in Cytochrome P450 (CYP)1A1- and 1A2-Null Mice: Roles of CYP1A1 and CYP1A2.
    Gastelum G, Jiang W, Wang L, Zhou G, Borkar R, Putluri N, Moorthy B.
    Toxicol Sci; 2020 Oct 01; 177(2):347-361. PubMed ID: 32726451
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.